Tunneled central venous catheter complications and the iatrogenic superior vena cava syndrome.
Presant
C A
CA
University of Southern California, School of Medicine, Los Angeles.
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control; D002177:Candidiasis / Q000209:etiology* / Q000517:prevention & control; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D009894:Opportunistic Infections / Q000209:etiology* / Q000517:prevention & control; D013479:Superior Vena Cava Syndrome / Q000209:etiology* / Q000517:prevention & control; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D014568:Urokinase-Type Plasminogen Activator